SEC Filing Details

Document Details

Form
Filing Date
May 16, 2024
Document Date
May 10, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Sensei Biotherapeutics, Inc
Issuer
SENSEI BIOTHERAPEUTICS, INC.
Filer
Gaiero David G

HQ: 1405 Research Blvd, Suite 125, Rockville, MD 20850

MA: 22 Boston Wharf Rd, 7th Floor,
Boston, MA 02210